Pepti review
Each fill runs 28 days, so a year carries thirteen charges rather than twelve.
The verdict
Pepti publishes $119 per fill for semaglutide and $139 for tirzepatide. Fills run 28 days, so a calendar month is $129 and $151. Coverage is 36 states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- States
- 36
- From
- From $129/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 36 states
Pepti sells both molecules as a weekly injection on a subscription that covers medication, physician care, labs and shipping. This site publishes no oral figure for Pepti.
Who writes the prescription, and what do they see?
The subscription is described as covering physician care and labs alongside the medication, which is a fuller statement of what is included than a bare medication price gives.
Bundling labs and physician care into one figure removes the two charges that most often appear later. The 28-day cycle is the detail that puts some of it back.
What happens when the dose goes up?
The rate is recorded as flat, so an escalation should not move it. No milligram is published beside either figure.
What the price includes
Six months of semaglutide at $129 a calendar month is $774, and tirzepatide at $151 is $906. The 28-day cycle is what lifts each fill price to its calendar-month figure.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name. The FDA does not review a compounded preparation before it is dispensed.
Where it holds up, and where it does not
- Strength: Physician care and labs stated as included
- Strength: Flat across doses
- Strength: Both fill prices published before intake
- Strength: Coverage in 36 states
- Limitation: Thirteen fills a year, not twelve
- Limitation: Fill prices understate a calendar month
- Limitation: No milligram dose is published
- Limitation: The pharmacy behind both lines is unnamed
What the evidence says about this kind of treatment
The assessment above is about Pepti. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants labs and physician care inside one figure and counts fills rather than months.
- Wrong for
- A reader budgeting fills as if they were months.
The evidence behind what Pepti prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Pepti compares
| Seller | Who it suits | Go |
|---|---|---|
 Midi Health | Readers who want every rung costed, with its milligram, before choosing a first dose | See Midi Health → |
 TelePeptide | Readers who want the whole commitment ladder priced in advance | See TelePeptide → |
 Rivo Health | Readers who want a flat rate and can ignore the seasonal framing | See Rivo Health → |
More GLP-1 telehealth sellers reviews: PrescrYbePRIMO Health PartnersPush HealthRavia HealthRed Mountain Weight LossRegenCen
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does a month cost?
- $129 for semaglutide and $151 for tirzepatide, once the 28-day cycle is converted to a calendar month.
- Why is a month more than a fill?
- Each fill covers 28 days, so thirteen land in a year. $119 a fill is $129 a calendar month, and $139 is $151.
- Is there an oral option?
- This site publishes no oral figure for Pepti. Its weight-loss category lists six injectable treatments, and the page that carried orals returns a 404.
- Is Pepti legit?
- Pepti is a GLP-1 telehealth sellers service. Its stated availability: 36 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Pepti expensive compared with other GLP-1 telehealth sellers?
- Pepti publishes a starting figure of $129/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Pepti below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.